Printer Friendly

SUMMIT TECHNOLOGY ANNOUNCES LASER SYSTEM SALES TO CHINA

 WALTHAM, Mass., Jan. 5 /PRNewswire/ -- Summit Technology, Inc. (NASDAQ: BEAM) announced today that it has sold and shipped two of its OmniMed(tm) refractive laser systems for delivery to the People's Republic of China (mainland). The company anticipates that these systems will be installed and operational within the first half of 1993. Summit believes it is the first company to deliver ophthalmic refractive laser systems for installation in the People's Republic of China (mainland).
 Summit Technology, Inc. has established the leadership position in designing, manufacturing and marketing ophthalmic refractive laser systems where applications have been developed for the treatment of common vision disorders such as nearsightedness, farsightedness, astigmatism, glaucoma and certain corneal irregularities due to disease or injury.
 -0- 1/5/93
 /CONTACT: Paula Rainville of Summit Technology, Inc., 617-890-1234/
 (BEAM)


CO: Summit Technology, Inc. ST: Massachusetts IN: MTC SU:

DD -- NE003 -- 1573 01/05/93 09:18 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jan 5, 1993
Words:149
Previous Article:NORTH STAR UNIVERSAL, INC., SELLS UNIVERSAL PRESS & LABEL SUBSIDIARY
Next Article:LORAD RECEIVES $1 MILLION ORDER FROM U.S. ARMY FOR MAMMOGRAPHY AND BIOPSY SYSTEMS
Topics:


Related Articles
SUMMIT TECHNOLOGY RECEIVES IDE FROM FDA FOR TREATMENT OF ASTIGMATISM WITH HOLMIUM LASER SYSTEM
SUMMIT TECHNOLOGY ANNOUNCES FDA APPROVAL TO BEGIN SECOND PHASE OF U.S. CLINICAL TRIALS USING HOLMIUM LASER FOR TREATMENT OF FARSIGHTEDNESS
SUMMIT TECHNOLOGY ANNOUNCES FDA APPROVAL TO BEGIN SECOND PHASE OF U.S. CLINICAL TRIALS USING HOLMIUM LASER FOR TREATMENT OF FARSIGHTEDNESS
SUMMIT RECEIVES FDA CLEARANCE TO SELL OMNIMED HOLMIUM LASER SYSTEM IN THE UNITED STATES
JAPANESE MOHW ACCEPTS FOR REVIEW SUMMIT'S COMMERCIAL MARKETING APPLICATION
FDA ACCEPTS SUMMIT'S APPLICATION TO COMMERCIALLY MARKET EXCIMER LASER SYSTEMS FOR TREATMENT OF MYOPIA
FDA ACCEPTS SUMMIT'S APPLICATION TO COMMERCIALLY MARKET EXCIMER LASER SYSTEMS FOR TREATMENT OF MYOPIA
SUMMIT TECHNOLOGY ANNOUNCES PATENT AWARDED FOR LASER THERMOKERATOPLASTY
SUMMIT RECEIVES AUTHORIZATION TO CONDUCT NEW CLINICAL TRIAL
SUMMIT RECEIVES FDA APPROVAL TO SELL EXCIMER LASER SYSTEM FOR PTK

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters